Lucid Diagnostics
(NASDAQ) LUCD
Lucid Diagnostics Financials at a Glance
Market Cap
$203.49M
Revenue (TTM)
$4.71M
Net Income (TTM)
$58.01M
EPS (TTM)
$-0.82
P/E Ratio
-1.40
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.16
Volume
6,859
Open
$1.15
Price
$1.16
Volume
6,859
Open
$1.15
Previous Close
$1.16
Daily Range
$1.15 - $1.16
52-Week Range
$0.95 - $1.70
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.16
Volume
6,859
Open
$1.15
Previous Close
$1.16
Daily Range
$1.15 - $1.16
52-Week Range
$0.95 - $1.70
LUCD News
LUCD Reports Results
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lucid Diagnostics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
82
CEO
Lishan Aklog, MD
Website
www.luciddx.comHeadquarters
New York City, NY 10165, US
LUCD Financials
Key Financial Metrics (TTM)
Gross Margin
-56%
Operating Margin
-11%
Net Income Margin
-12%
Return on Equity
-711%
Return on Capital
-4%
Return on Assets
-1%
Earnings Yield
-71.43%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$203.49M
Shares Outstanding
176.95M
Volume
6.86K
Short Interest
0.00%
Avg. Volume
1.28M
Financials (TTM)
Gross Profit
$2.84M
Operating Income
$49.64M
EBITDA
$48.77M
Operating Cash Flow
$46.48B
Capital Expenditure
$197.00K
Free Cash Flow
$46.48B
Cash & ST Invst.
$34.70B
Total Debt
$25.82B
Lucid Diagnostics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.50M
+25.6%
Gross Profit
$565.00K
+40.4%
Gross Margin
-37.57%
N/A
Market Cap
$203.49M
N/A
Market Cap/Employee
$2.83M
N/A
Employees
72
N/A
Net Income
$16.27M
-40.9%
EBITDA
$13.80M
-22.0%
Quarterly Fundamentals
Net Cash
$34.68B
+3141130.1%
Accounts Receivable
$643.00K
+58.8%
Inventory
$353.00M
+103419.1%
Long Term Debt
$927.00K
-48.5%
Short Term Debt
$24.89M
+28.0%
Return on Assets
-1.43%
N/A
Return on Invested Capital
-4.18%
N/A
Free Cash Flow
$12.63M
-24.7%
Operating Cash Flow
$12.58M
-27.4%